Estimated Costs of Endocrine-Disrupting Chemical Exposure Exceed €150 Billion Annually in EU

A series of peer-reviewed studies published last night finds that human exposure to EDCs contribute to a number of diseases and disabilities with costs in the hundreds of billions of Euros per year.

“Estimating Burden and Disease Costs of Exposure to Endocrine Disrupting Chemicals in The European Union” is published online in the peer-reviewed Journal of Clinical Endocrinology and Metabolism.

The scientists say that the likely costs in the EU total €157 billion ($209 billion) a year in health care expenses and lost earning potential. (See Endocrine Society Press release 5 March 2015)

Leading experts in this field concluded that infertility and male reproductive dysfunctions, birth defects, obesity, diabetes, cardiovascular disease, and neurobehavioral and learning disorders were among the conditions that can be partly attributed to people’s exposure to EDCs.

More information:

Post provided by EDC-Free Secretariat HEAL